Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Arcturus Therapeutics (ARCT) has shared an update.
Arcturus Therapeutics Holdings Inc. stockholders convened for their annual meeting, endorsing a significant amendment to the company’s equity incentive plan by increasing share allocation to participants by 2 million, totaling 10.75 million shares. Additionally, the assembly re-elected eight board members, validated executive compensation in a non-binding vote, and ratified the appointment of Deloitte & Touche LLP as their independent auditor for the upcoming fiscal year.
For an in-depth examination of ARCT stock, go to TipRanks’ Stock Analysis page.